Effects of a sodium glucose co‐transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring

Publisher: John Wiley & Sons Inc

E-ISSN: 2040-1124|6|6|699-707

ISSN: 2040-1116

Source: Journal Of Diabetes Investigation, Vol.6, Iss.6, 2015-11, pp. : 699-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract